LFG Wealth Partners LLC Makes New $340,000 Investment in Humana Inc. $HUM

LFG Wealth Partners LLC bought a new position in Humana Inc. (NYSE:HUM) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 1,326 shares of the insurance provider’s stock, valued at approximately $340,000.

Other large investors have also modified their holdings of the company. Revolve Wealth Partners LLC purchased a new position in Humana in the 4th quarter worth about $202,000. Woodline Partners LP lifted its stake in Humana by 460.0% in the first quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock worth $2,697,000 after acquiring an additional 8,372 shares during the period. Sivia Capital Partners LLC lifted its stake in Humana by 53.7% in the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock worth $316,000 after acquiring an additional 452 shares during the period. Cresset Asset Management LLC raised its holdings in shares of Humana by 10.3% in the 2nd quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock valued at $581,000 after purchasing an additional 222 shares in the last quarter. Finally, WINTON GROUP Ltd raised its holdings in shares of Humana by 58.5% in the 2nd quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock valued at $582,000 after purchasing an additional 879 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Price Performance

Humana stock opened at $380.27 on Tuesday. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $380.79. The company’s fifty day moving average price is $271.95 and its 200 day moving average price is $238.26. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The stock has a market capitalization of $45.66 billion, a P/E ratio of 40.67, a P/E/G ratio of 2.16 and a beta of 0.76.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The company had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The firm’s revenue for the quarter was up 23.5% on a year-over-year basis. During the same quarter last year, the firm posted $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, equities research analysts anticipate that Humana Inc. will post 9.04 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio is presently 37.86%.

Wall Street Analysts Forecast Growth

HUM has been the subject of several recent analyst reports. Raymond James Financial restated an “outperform” rating and issued a $260.00 target price on shares of Humana in a research note on Friday, May 1st. Bank of America raised their price objective on Humana from $267.00 to $340.00 and gave the stock a “neutral” rating in a research note on Thursday, June 4th. Guggenheim lifted their price objective on shares of Humana from $252.00 to $269.00 and gave the company a “buy” rating in a research note on Thursday, April 30th. Royal Bank Of Canada restated a “sector perform” rating on shares of Humana in a research report on Monday, June 1st. Finally, Seaport Research Partners downgraded Humana to a “neutral” rating in a research report on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, sixteen have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $291.35.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.